News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Big Bets Aim to Jolt Heart Drug Sales Back to Life



8/29/2012 8:22:40 AM

The expiry of patents on profitable heart medicines is soon going to erode one of the main sources of drug company profits, and risky bets on new medicines to replace them may not make up for the lost sales. High-octane salesmanship was still on show at giant trade stands during this week's European Society of Cardiology congress - the world's biggest heart meeting with 28,000 participants - but the razzmatazz hides a business in trouble.

Read at Reuters


comments powered by Disqus
Reuters
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES